Details for Patent: 8,603,506
✉ Email this page to a colleague
Title: | Methods of treating acne |
Abstract: | A method of treating acne in a human in need thereof comprising administering systemically to said human a tetracycline compound in an amount that is effective to treat acne but has substantially no antibiotic activity, without administering a bisphosphonate compound. |
Inventor(s): | Ashley; Robert A. (Newtown, PA) |
Assignee: | Galderma Laboratories, Inc. (Fort Worth, TX) |
Filing Date: | Oct 20, 2011 |
Application Number: | 13/277,789 |
Claims: | 1. A method for treating papules and pustules of rosacea in a human in need thereof, the method comprising administering orally to said human doxycycline, or a pharmaceutically acceptable salt thereof, in an amount that (i) is effective to treat the papules and pustules of rosacea; (ii) is 10-80% of a 50 mg dose of doxycycline per day; and (iii) results in no reduction of skin microflora during a six-month treatment, without administering a bisphosphonate compound. 2. The method according to claim 1, wherein said doxycycline is doxycycline monohydrate. 3. The method according to claim 2, wherein said doxycycline monohydrate is administered in an amount of 40 milligrams. 4. The method according to claim 3, wherein said doxycycline monohydrate is administered by sustained release. 5. A method according to claim 4, wherein said doxycycline monohydrate is administered once a day. 6. The method according to claim 2, wherein said doxycycline monohydrate is administered in a dose of 20 mg twice a day. 7. The method according to claim 1, wherein said doxycycline, or a pharmaceutically acceptable salt thereof, is administered in an amount which provides a serum concentration in the range of about 0.1 to about 0.8 .mu.g/ml. 8. A method for treating papules and pustules of rosacea in a human in need thereof, the method comprising administering orally to said human doxycycline, or a pharmaceutically acceptable salt thereof, in an amount that (i) is effective to treat the papules and pustules of rosacea; (ii) is 40-80% of a 50 mg dose of doxycycline per day; and (iii) results in no reduction of skin microflora during a six-month treatment, without administering a bisphosphonate compound. 9. The method according to claim 8, wherein said doxycycline is doxycycline monohydrate. 10. The method according to claim 9, wherein said doxycycline monohydrate is administered in an amount of 40 milligrams. 11. The method according to claim 10, wherein said doxycycline monohydrate is administered by sustained release. 12. A method according to claim 11, wherein said doxycycline monohydrate is administered once a day. 13. The method according to claim 9, wherein said doxycycline monohydrate is administered in a dose of 20 mg twice a day. 14. The method according to claim 8, wherein said doxycycline, or a pharmaceutically acceptable salt thereof, is administered in an amount which provides a serum concentration in the range of about 0.1 to about 0.8 .mu.g/ml. 15. A method for treating papules and pustules of rosacea in a human in need thereof, the method comprising administering orally to said human doxycycline, or a pharmaceutically acceptable salt thereof, in an amount of 40 mg per day, wherein the amount results in no reduction of skin microflora during a six-month treatment, without administering a bisphosphonate compound. 16. The method according to claim 15, wherein said doxycycline is doxycycline monohydrate. 17. The method according to claim 16, wherein said doxycycline monohydrate is administered by sustained release. 18. A method according to claim 17, wherein said doxycycline monohydrate is administered once a day. 19. The method according to claim 16, wherein said doxycycline monohydrate is administered in a dose of 20 mg twice a day. 20. The method according to claim 15, wherein said doxycycline, or a pharmaceutically acceptable salt thereof, is administered in an amount which provides a serum concentration in the range of about 0.1 to about 0.8 .mu.g/ml. |